abstract |
Hybrid Anti-Inflammatory Agent, Pharmaceutical Composition, Hybrid Arti-Inflammatory Agent Preparation Process and Use of the Hybrid Anti-Inflammatory Agent The present invention relates to cationic lipid hybrid anti-inflammatory agents and readily available anti-inflammatory drugs for pharmaceutical, medical and pharmaceutical applications. hospital, veterinary, biotechnological, oncological, biomedical or preventive. |